News

CEO Serge Saxonov, PhD, acknowledged that its R&D operation “definitely ended up being impacted in a substantial way” while ...
Biotech rivals agree global patent cross-licences and end all litigation | 10x ‘expects’ to receive $68m plus royalties on ...
Bruker (BRKR) and 10x Genomics (TXG) have reached a final settlement to resolve their patent disputes and dismiss multiple litigations, with global patent cross-license agreements between the two ...
Shares of 10x Genomics (TXG) have gained 14.7% over the past four weeks to close the last trading session at $9.49, but there ...